Sign In
|
|
Free Newsletters
Finance Resource Center
D&B Credit Reports
Businesses for Sale
What's Your Credit Emergency?
Thriving in Tough Times
Trade Magazines
Home
Topics
Bloggers
Franchises
Videos
Podcasts
Library
Ask the Experts
Shop Legal Forms
Find Vendors
Careers
|
Green Business
|
Starting a Business
|
Sales & Selling
|
Business Credit
|
Women in Business
|
Web Tools
|
Company Profiles
Careers
|
Green Business
|
Starting a Business
|
Sales & Selling
|
Business Credit
|
Women in Business
|
Web Tools
|
Company Profiles
Business Travel
|
Manufacturing
|
Retail
|
Sales
|
Starting a Business
|
Technology
|
> See All Topics
|
> See All Industries
Business Intelligence
|
Small Business Blog
|
Finance
|
Operations
|
Sales
|
Technology
|
> See All
AllBusiness AllStars
|
Franchise Directory
|
Buying a Franchise
|
Growing Your Franchise
|
Franchising Your Business
Human Resources
|
Franchises
|
Manufacturing
|
Marketing & Advertising
|
Sales
|
Technology
|
> See All
Finance
|
Green Business
|
Sales
|
Starting a Company
|
Technology
|
Women in Business
|
> See All
Professional Journals
|
Business Answers
|
Company Profiles
|
Glossary
Business Travel
|
Entrepreneurship
|
Finance
|
Franchising
|
Inventing
|
Sales
|
B2B Sales
Form Kits
|
Letter of Intent
|
Web Sites
|
Confidentiality
|
Employment
|
Consulting
|
Due Diligence
|
Demand Letters
|
Business Guides
> See All
Business Directory
|
Quote Center
|
Partner Resources
Drug & Medical Devices Approval
The best tips and advice from our vast library of articles, videos, and business tools
Browse Related Topics
Health Care Law
Legal
Tools
Businesses for Sale
Business Cash Advance
Business Directory
Lead Lists
Free Magazines
Free Industry Resources
Newly Added Articles
SAS looking at sun power
Not Milton Hershey's candy bar anymore
Genius Products Expands into Publishing and...
MUSIC LAB'S SOUND TRAVELS
Cigarette firms warned that ad ban could pose...
City may intensify downtown parking enforcement
Seeding meetings another victim of Internet age
FDA Approvals
FDA Reform
FDA Review
Search Results
1-20
of 1150 related articles
Best Of
Past 30 Days
This Year
Past 5 Years
All Dates
Renovis Raises $45M In Series E Round For Product Development.
Staff Writer Less than a year after building its pipeline through an acquisition, Renovis Inc. raised $45 million...
unaggregatedarticle
Zeltia Mulls Options Following EU Rejection Of Sarcoma Drug.
BioWorld International Correspondent Spanish firm Zeltia SA is considering its options following the failure last week of its...
unaggregatedarticle
The Daily Record News Briefs: November 5, 2009
Boost for GenVec GenVec Inc., of Gaithersburg, a biopharmaceutical company developing novel gene-based drugs and vaccines, said its...
unaggregatedarticle
Allos Raises $15 Million In Private Placement With Perseus-Soros</B><FONT SIZE=4>.
Staff Writer Allos Therapeutics Inc. completed a private placement of 2.5 million shares of stock to Perseus-Soros Pharmaceutical...
unaggregatedarticle
Tests of time D-FW sees growth in clinical trials as firms seek quicker drug approval
Testing a new drug on patients used to be done at universities, which could count on hundreds of...
unaggregatedarticle
Antigenics Announces a Negative Vote From the CHMP on Oncophage[R] Marketing Application in Europe.
Antigenics Inc. ( NASDAQ: AGEN ) announced that the Committee for Medicinal Products for Human Use (CHMP), of...
unaggregatedarticle
New drug abuse study findings recently were reported by B.A. Martelland co-researchers.
"Cocaine dependence, which affects 2.5 million Americans annually,has no US Food and Drug Administration-approved pharmacotherapy. To evaluate the...
unaggregatedarticle
United States: Biosimilars Provision Included In House Health Care Reform Bill - The Time Has Finally Come
On October 29, 2009, the Democratic leadership of the House of Representatives released the Affordable Health Care for...
unaggregatedarticle
Advanced Magnetics Plans NDA On Phase III Ferumoxytol Data.
Staff Writer Advanced Magnetics Inc. reported positive data from the fourth andfinal Phase III trial of its intravenous...
unaggregatedarticle
MIKULSKI, CARDIN URGE OMB DIRECTOR TO SUPPORT FUNDING FOR WHITE OAK CONSOLIDATION
The following information was released by Maryland Senator Barbara A. Mikulski : U.S. Senators Barbara A. Mikulski and...
unaggregatedarticle
Senate Passes Reimportation Amendment; Vote Weeks Away.
Washington Editor WASHINGTON - The Senate debate over prescription drug coverage forthe elderly took a nasty turn Wednesday...
unaggregatedarticle
Clinic Roundup.
o BioMimetic Therapeutics Inc., of Franklin, Tenn., completed enrollment in its Canadian pilot study with its lead candidate,...
unaggregatedarticle
HHS ORDERS INTRAVENOUS ANTIVIRAL FLU MEDICATION TO HELP PATIENTS HOSPITALIZED WITH 2009 H1N1
The following information was released by the Department of Health and Human Services: The U.S. Department of Health...
unaggregatedarticle
Biosimilars Provision Included In House Health Care Reform Bill - The Time Has Finally Come.
On October 29, 2009, the Democratic leadership of the House of Representatives released the Affordable Health Care for...
unaggregatedarticle
Oscient Paying Reliant $78M For Cholesterol Drug In U.S.
West Coast Editor Oscient Pharmaceuticals Inc. is gaining a piece of the fenofibratemarket with its buyout of U.S....
unaggregatedarticle
Santaris Signs $200M LNA Oncology Pact With Enzon.
BioWorld International Correspondent Santaris Pharma A/S gained commercial validation for its Locked Nucleic Acid (LNA) oligonucleotide analogue chemistry...
unaggregatedarticle
Other News To Note.
o Advanced Cell Technology Inc., of Alameda, Calif., and the WiCell Research Institute in Madison, Wis., agreed to...
unaggregatedarticle
Other News To Note.
o Array BioPharma Inc., of Boulder, Colo., expanded a collaboration with South San Francisco-based Genentech Inc. to develop...
unaggregatedarticle
Cyclacel Boosts Clinical Work With $45M Private Placement.
Staff Writer A month after gaining access to public markets through a merger with Xcyte Therapeutics Inc., Cyclacel...
unaggregatedarticle
Somaxon Launches Phase III Insomnia Trials With Silenor.
West Coast Editor Days after raising $65 million in a Series C financing, Somaxon Pharmaceuticals Inc. is kicking...
unaggregatedarticle
1-20
of 1150 related articles
1
2
3
4
5
6
7
8
9
10
Next
Press Releases
Global Precision Medical Inc.: Legal Domicile Moved...
St. Jude Medical Announces FDA Approval of Epic II...
Medtronic Statement Regarding U.S. SupremeCourt's...
How to Turn Your Business Dream into a Successful Reality
Napa Valley business owners tell Sumer Morenz of D&B Digital TV how they turned passion into bottom-line success.
Franchise Finder
Find your perfect franchise
Choose your location and industry and we'll show you the most relevant franchises.
Industry:
All Industries
Automotive Franchises
Business-to-Business Franchises
Children's Franchises
General Service Franchises
Health and Wellness Franchises
Home Service Franchises
Personal Care Franchises
Personal Finance Franchises
Pet Franchises
Restaurant and Food Franchises
Retail Franchises
Travel and Leisure Franchises
Location:
All Locations
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Worldwide
Africa
Asia
Australia/New Zealand
Canada
Central America
Europe
Mexico
Middle East
South America
Premium Content
Which rules must we follow? Sorting out compliance...
As Technology Progresses, Future of Jarvik Heart...
How to speed up drug approval. (Part II: Safety...